Position in AMGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$339,306
-$581 QoQ
Shares Held
937
-3.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#2,467
of 3,140 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SEEDS INVESTOR LLC holds $7,766,038 across 8 Drug Manufacturers - General names. AMGN ranks #8 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,515 | $3,016,566 | |
| 2 | ABBV |
AbbVie Inc.
|
4,040 | $1,016,625 | |
| 3 | NVS |
Novartis AG
|
6,174 | $967,589 | |
| 4 | JNJ |
Johnson & Johnson
|
3,098 | $786,799 | |
| 5 | MRK |
Merck & Co., Inc.
|
5,502 | $707,007 | |
| 6 | AZN |
Astrazeneca PLC
|
2,548 | $483,151 | |
| 7 | PFE |
Pfizer Inc
|
18,646 | $448,995 | |
| 8 | AMGN |
Amgen Inc
This page
|
937 | $339,306 |
All Filings in AMGN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $339,306 | 937 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $339,887 | 966 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $303,743 | 928 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $250,029 | 886 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $264,691 | 948 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $332,423 | 1,067 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $344,044 | 1,320 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $496,525 | 1,541 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $395,561 | 1,266 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $216,083 | 760 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $337,847 | 1,173 | Shares | Sole | 2024-05-07 | |
| No filing history on record for this holder in this stock. | ||||||